Guardrails for the use of generalist AI in cancer care

Stephen Gilbert,Jakob Nikolas Kather
DOI: https://doi.org/10.1038/s41568-024-00685-8
IF: 78.5
2024-04-17
Nature Reviews Cancer
Abstract:Artificial narrow intelligence models, trained for specific intended purposes, have gained approval and recommendation for cancer treatment. Generalist medicial artificial intelligence (GMAI) models are now being developed for cancer treatment. Policy makers have a stark choice: radically adapt frameworks, block generalist approaches or force them onto narrower tracks. Generalist medical artificial intelligence (GMAI) models are gaining momentum in their applications for cancer treatment. In this Comment, Gilbert and Kather advocate for novel regulation of GMAI approaches to ensure patient safety and adequate physician support.
oncology
What problem does this paper attempt to address?